INTERPACE BIOSCIENCES, INC. Asset Impairment Charges
INTERPACE BIOSCIENCES, INC. (IDXG) reported Asset Impairment Charges of $198.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-08-10
- INTERPACE BIOSCIENCES, INC. asset impairment charges for the quarter ending 2025-12-31 was $0.00.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for the quarter ending 2025-09-30 was $0.00.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for the quarter ending 2025-06-30 was $198.00K.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for the quarter ending 2025-03-31 was $0.00.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for fiscal 2025 was $198.00K.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for fiscal 2020 was $37.00K.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for fiscal 2016 was $11.60M, a 1726.77% increase from fiscal 2015.
- INTERPACE BIOSCIENCES, INC. asset impairment charges for fiscal 2015 was $635.00K, a 69.56% decline from fiscal 2014.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month | Asset Impairment Charges 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $198.00K derived: sum of 3 quarters · filed 2026-03-30 | $198.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $198.00K derived: sum of 2 quarters · filed 2025-11-12 | $198.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $198.00K 10-Q · filed 2025-08-07 | $198.00K 10-Q · filed 2026-08-10 | |||
| 2025-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-03-30 | ||||
| 2020-12-31 | $37.00K 10-K · filed 2022-03-31 | ||||
| 2016-12-31 | $8.24M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-01-19 | $11.60M derived: sum of 2 quarters · filed 2021-01-19 | $11.60M 10-K/A · filed 2021-01-19 | $3.36M 10-K · filed 2017-03-31 | |
| 2016-09-30 | $3.36M 10-Q · filed 2017-11-13 | $3.36M 10-Q · filed 2017-11-13 | |||
| 2015-12-31 | $635.00K 10-K · filed 2017-03-31 | ||||
| 2014-12-31 | $600.00K 10-K · filed 2016-03-30 | $2.09M 10-K · filed 2016-03-30 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-03-05 | ||||
| 2012-12-31 | $23.52M 10-K · filed 2014-03-06 | ||||
| 2011-12-31 | $0.00 10-K · filed 2013-03-15 |